                               SEQUENCE LISTING

<110> OSSIANIX, INC.
 
<120> HIGH AFFINITY HUMAN AND MONKEY SPECIFIC TFR-1 VNARS

<130> 9030.2001-wo1

<140> PCT/US2021/058661
<141> 2021-11-09

<150> 63/234,210
<151> 2021-08-17

<150> 63/112,314
<151> 2020-11-11

<160> 9     

<170> PatentIn version 3.5

<210> 1
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 1
Asp Ser Asn Cys Ala Leu Ser Ser 
1               5               


<210> 2
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 2
Val Val Gly Thr Trp Cys Met Ser Trp Arg Asp Val 
1               5                   10          


<210> 3
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 3
Thr Asn Glu Glu Asn Ile Ser Lys Gly 
1               5                   


<210> 4
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      peptide"

<400> 4
Ser Gly Ser Lys Ser 
1               5   


<210> 5
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 5
Ala Arg Val Asp Gln Thr Pro Gln Thr Ile Thr Lys Glu Thr Gly Glu 
1               5                   10                  15      


Ser Leu Thr Ile Asn Cys Val Leu Arg Asp Ser Asn Cys Ala Leu Ser 
            20                  25                  30          


Ser Thr Tyr Trp Tyr Arg Lys Lys Ser Gly Ser Thr Asn Glu Glu Asn 
        35                  40                  45              


Ile Ser Lys Gly Gly Arg Tyr Val Glu Thr Val Asn Ser Gly Ser Lys 
    50                  55                  60                  


Ser Phe Ser Leu Lys Ile Asn Asp Leu Thr Val Glu Asp Ser Gly Thr 
65                  70                  75                  80  


Tyr Arg Cys Asn Val Val Gly Thr Trp Cys Met Ser Trp Arg Asp Val 
                85                  90                  95      


Tyr Gly Gly Gly Thr Ala Val Thr Val Asn Ala 
            100                 105         


<210> 6
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 6
Ala Arg Val Asp Gln Thr Pro Gln Thr Ala Thr Lys Glu Thr Gly Glu 
1               5                   10                  15      


Ser Leu Thr Ile Asn Cys Val Leu Arg Asp Ser Asn Cys Ala Leu Ser 
            20                  25                  30          


Ser Thr Tyr Trp Tyr Arg Lys Lys Ser Gly Ser Thr Asn Glu Glu Asn 
        35                  40                  45              


Ile Ser Lys Gly Gly Arg Tyr Val Glu Thr Val Asp Ser Gly Thr Lys 
    50                  55                  60                  


Ser Phe Ser Leu Lys Ile Asn Asp Leu Thr Val Glu Asp Ser Gly Thr 
65                  70                  75                  80  


Tyr Arg Cys Asn Val Val Gly Thr Trp Cys Met Ser Trp Arg Asp Val 
                85                  90                  95      


Ser Gly Asp Gly Thr Val Val Thr Val Asn Ala 
            100                 105         


<210> 7
<211> 108
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 7
Ala Arg Val Asp Gln Thr Pro Gln Thr Ala Thr Lys Glu Thr Gly Glu 
1               5                   10                  15      


Ser Leu Thr Ile Asn Cys Val Leu Arg Asp Ser Asn Cys Ala Leu Ser 
            20                  25                  30          


Ser Thr Tyr Trp Tyr Arg Lys Lys Ser Gly Ser Thr Asn Glu Glu Asn 
        35                  40                  45              


Ile Ser Lys Gly Gly Arg Lys Tyr Val Glu Thr Val Glu Ser Gly Ser 
    50                  55                  60                  


Lys Ser Phe Ser Leu Lys Ile Asn Asp Leu Thr Val Glu Asp Ser Gly 
65                  70                  75                  80  


Thr Tyr Arg Cys Asn Val Val Gly Thr Trp Cys Met Ser Trp Arg Asp 
                85                  90                  95      


Val Ser Gly Asp Gly Thr Val Val Thr Val Asn Ala 
            100                 105             


<210> 8
<211> 107
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 8
Ala Arg Val Asp Gln Thr Pro Gln Thr Ala Thr Lys Glu Thr Gly Glu 
1               5                   10                  15      


Ser Leu Thr Ile Asn Cys Val Leu Arg Asp Ser Asn Cys Ala Leu Ser 
            20                  25                  30          


Ser Thr Tyr Trp Tyr Arg Lys Lys Ser Gly Ser Thr Asn Glu Glu Asn 
        35                  40                  45              


Ile Ser Lys Gly Gly Arg Tyr Val Glu Thr Val Asp Ser Gly Thr Lys 
    50                  55                  60                  


Ser Phe Ser Leu Lys Ile Asn Asp Leu Thr Val Glu Asp Ser Gly Thr 
65                  70                  75                  80  


Tyr Arg Cys Asn Val Val Gly Thr Trp Cys Met Ser Trp Arg Asp Val 
                85                  90                  95      


Ser Gly Asp Gly Thr Val Val Thr Val Asn Ala 
            100                 105         


<210> 9
<211> 108
<212> PRT
<213> Artificial Sequence

<220>
<221> source
<223> /note="Description of Artificial Sequence: Synthetic
      polypeptide"

<400> 9
Ala Arg Val Asp Gln Thr Pro Gln Thr Ala Thr Lys Glu Thr Gly Glu 
1               5                   10                  15      


Ser Leu Thr Ile Asn Cys Val Leu Arg Asp Ser Asn Cys Ala Leu Ser 
            20                  25                  30          


Ser Thr Tyr Trp Tyr Arg Lys Lys Ser Gly Ser Thr Asn Glu Glu Asn 
        35                  40                  45              


Ile Ser Lys Gly Gly Arg Lys Tyr Val Glu Thr Val Glu Ser Gly Ser 
    50                  55                  60                  


Lys Ser Phe Ser Leu Lys Ile Asn Asp Leu Thr Val Glu Asp Ser Gly 
65                  70                  75                  80  


Thr Tyr Arg Cys Asn Val Val Gly Thr Trp Cys Met Ser Trp Arg Asp 
                85                  90                  95      


Val Ser Gly Asp Gly Thr Val Val Thr Val Asn Ala 
            100                 105             


